ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,481.00
-0.66%
S&P ASX All Technology
4,103.10
-0.30%
Brent Oil
75.375
0.32%
US Dollar vs AUD
1.57245
-0.06%
Bitcoin
95,744.79
-0.03%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) News

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BPTH
DateTimeSourceHeadlineSymbolCompany
15/02/202509:26Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BPTHBio Path Holdings Inc
14/02/202508:01GlobeNewswire Inc.Bio-Path Holdings Expands Global Patent PortfolioNASDAQ:BPTHBio Path Holdings Inc
14/02/202500:00GlobeNewswire Inc.Bio-Path Holdings Provides Key Clinical UpdatesNASDAQ:BPTHBio Path Holdings Inc
13/02/202508:01GlobeNewswire Inc.Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid LeukemiaNASDAQ:BPTHBio Path Holdings Inc
13/02/202502:59Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BPTHBio Path Holdings Inc
21/01/202522:10Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
11/01/202508:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
10/01/202523:00GlobeNewswire Inc.Bio-Path Holdings Provides 2025 Clinical and Operational UpdateNASDAQ:BPTHBio Path Holdings Inc
20/12/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
19/12/202423:00GlobeNewswire Inc.Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin SensitivityNASDAQ:BPTHBio Path Holdings Inc
14/12/202409:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
13/12/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
11/12/202423:00GlobeNewswire Inc.Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes PatientsNASDAQ:BPTHBio Path Holdings Inc
26/11/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
15/11/202423:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
15/11/202423:00GlobeNewswire Inc.Bio-Path Holdings Reports Third Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
14/11/202403:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
08/11/202423:00GlobeNewswire Inc.Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024NASDAQ:BPTHBio Path Holdings Inc
07/11/202408:52Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
29/10/202407:37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BPTHBio Path Holdings Inc
29/10/202407:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
29/10/202407:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
23/10/202422:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BPTHBio Path Holdings Inc
23/10/202415:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BPTHBio Path Holdings Inc
23/10/202406:11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BPTHBio Path Holdings Inc
19/10/202408:12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
18/10/202407:37Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
11/10/202408:24GlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
09/10/202411:00GlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
08/10/202422:00GlobeNewswire Inc.Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of ObesityNASDAQ:BPTHBio Path Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:BPTH

Your Recent History

AQSE
SBUL.GB
WT 1x Daily Short Gold
BIT
UC63CC
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads